Background: HIV sero status disclosure and adherence to Highly Active Antiretroviral Therapy (HAART) medication are important for the prevention and control of HIV/AIDS. Little is known about the relationship between HIV positive status disclosure and highly active anti-retroviral therapy (HAART) adherence in developing countries including Ethiopia. The aim of this study was to explore the relationship between HIV status disclosure and HAART adherence.
No takes yet. Share an insight, caveat, or question.
Shewaye Fituma (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: